Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemical Conjugate of Low Molecular Weight Heparin and Suramin Fragment Inhibits Tumor Growth Possibly by Blocking VEGF165
Jooho Park, Jiyoung Kim, Seung Rim Hwang, et al.
Molecular Pharmaceutics (2015) Vol. 12, Iss. 11, pp. 3935-3942
Closed Access | Times Cited: 21

Showing 21 citing articles:

Recent advances in polysaccharides based biomaterials for drug delivery and tissue engineering applications
Ankur Sood, Aastha Gupta, Garima Agrawal
Carbohydrate Polymer Technologies and Applications (2021) Vol. 2, pp. 100067-100067
Open Access | Times Cited: 160
The anti-cancer properties of heparin and its derivatives: a review and prospect
Sainan Ma, Zhixiang Mao, Yang Wu, et al.
Cell Adhesion & Migration (2020) Vol. 14, Iss. 1, pp. 118-128
Open Access | Times Cited: 82
Heparin and Its Derivatives: Challenges and Advances in Therapeutic Biomolecules
Nipa Banik, Seong-Bin Yang, Tae‐Bong Kang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10524-10524
Open Access | Times Cited: 34
An Overview of Antitumour Activity of Polysaccharides
Hongzhen Jin, Maohua Li, Tian Feng, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 8083-8083
Open Access | Times Cited: 23
Sigma receptor-mediated targeted delivery of anti-angiogenic multifunctional nanodrugs for combination tumor therapy
Yuanke Li, Yuanyuan Wu, Leaf Huang, et al.
Journal of Controlled Release (2016) Vol. 228, pp. 107-119
Closed Access | Times Cited: 46
Repurposing suramin for the treatment of breast cancer lung metastasis with glycol chitosan-based nanoparticles
Bei Cheng, Feng Gao, Erica S. Maissy, et al.
Acta Biomaterialia (2018) Vol. 84, pp. 378-390
Open Access | Times Cited: 44
Chitosan–Polycaprolactone Core–Shell Microparticles for Sustained Delivery of Bevacizumab
Pengfei Jiang, Kane M. Jacobs, Matthew Ohr, et al.
Molecular Pharmaceutics (2020) Vol. 17, Iss. 7, pp. 2570-2584
Closed Access | Times Cited: 37
LMWH and its derivatives represent new rational for cancer therapy: construction strategies and combination therapy
Shi Du, Yao Yu, Cheng Xu, et al.
Drug Discovery Today (2019) Vol. 24, Iss. 10, pp. 2096-2104
Closed Access | Times Cited: 31
Multifaceted role of heparin in oncology: from anticoagulation to anticancer mechanisms and clinical implications
Niranjan Koirala, Melina Poudel, Amit Kumar Shrivastava, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Chitosan sulfate inhibits angiogenesisviablocking the VEGF/VEGFR2 pathway and suppresses tumor growthin vivo
Yingying Li, Wei Wang, Yapei Zhang, et al.
Biomaterials Science (2019) Vol. 7, Iss. 4, pp. 1584-1597
Closed Access | Times Cited: 21
Self-assembled nanocomplex of PEGylated protamine and heparin–suramin conjugate for accumulation at the tumor site
Jooho Park, Seung Rim Hwang, Jeong Uk Choi, et al.
International Journal of Pharmaceutics (2017) Vol. 535, Iss. 1-2, pp. 38-46
Closed Access | Times Cited: 19
Anti-tumour activity of low molecular weight heparin doxorubicin nanoparticles for histone H1 high-expressive prostate cancer PC-3M cells
Shuang Zhang, Zhantao Li, Man Liu, et al.
Journal of Controlled Release (2018) Vol. 295, pp. 102-117
Closed Access | Times Cited: 18
Interaction of vascular endothelial growth factor and heparin quantified by single molecule force spectroscopy
Miaomiao Zhang, Ying Liu, Fengchao Cui, et al.
Nanoscale (2020) Vol. 12, Iss. 22, pp. 11927-11935
Closed Access | Times Cited: 12
Bio-inspired drug-dominated supramolecular nanocomplex based on low molecular weight heparin for progressive tumor therapy
Yao Yu, Cheng Xu, Le Zhen, et al.
Carbohydrate Polymers (2019) Vol. 220, pp. 30-42
Closed Access | Times Cited: 11
Towards an emerging role for anticoagulants in cancer therapy: a systematic review and meta-analysis
Huda Moutaz Asmael Al‐Azzawi, Syed Ameer Hamza, Rita Paolini, et al.
Frontiers in Oral Health (2024) Vol. 5
Open Access | Times Cited: 1
Sensitive Detection of Coralyne and Heparin Using a Singly Labeled Fluorescent Oligonucleotide Probe
Xingxing Zhu, Miangjian Chen, Changbei Ma
ChemistrySelect (2019) Vol. 4, Iss. 19, pp. 5686-5690
Closed Access | Times Cited: 7
Anticancer Effect of Heparin–Taurocholate Conjugate on Orthotopically Induced Exocrine and Endocrine Pancreatic Cancer
Hae Hyun Hwang, Hee Jeong Jeong, Sangwu Yun, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5775-5775
Open Access | Times Cited: 5
Molecular Targeting of VEGF with a Suramin Fragment–DOCA Conjugate by Mimicking the Action of Low Molecular Weight Heparins
Jooho Park, Tae‐Bong Kang, Ji-Hong Lim, et al.
Biomolecules (2020) Vol. 11, Iss. 1, pp. 46-46
Open Access | Times Cited: 4
Suramin inhibits phenotypic transformation of vascular smooth muscle cells and neointima hyperplasia by suppressing transforming growth factor beta receptor 1 /Smad2/3 pathway activation
Yingjie Xu, Luning Ge, Yanan Rui, et al.
European Journal of Pharmacology (2024) Vol. 968, pp. 176422-176422
Closed Access
Plant-Based Biomaterials in Tissue Engineering and Drug Delivery Systems
Azadeh Izadyari Aghmiuni, Arezoo Ghadi, Elmira Azmoun
Engineering materials (2023), pp. 153-197
Closed Access
Potential targets of heparin during progression and metastasis of malignant neoplasms
В. В. Малащенко, И. А. Хлусов, K. А. Yurova, et al.
Medical Immunology (Russia) (2023) Vol. 26, Iss. 2, pp. 237-252
Open Access
Page 1

Scroll to top